Sign In | Join Free | My himfr.com |
|
Ask Lasest Price | |
Brand Name : | sincoheren, Monaliza ,ExQ-Laser |
Model Number : | Monaliza-2 |
Certification : | CE,Medical CE,FDA,TGA,TUV,CFDA |
Price : | Negotiable |
Payment Terms : | L/C, T/T, Western Union |
Supply Ability : | 10 sets per week |
Delivery Time : | 1-3 weeks |
Beijing Sincoheren Monaliza Q Switched Nd Yag laser skin care pigmentation removal machine
Product Description
ExQ-Laser Therapy Systems
1. Pigmented lesion: Yiteng lentigines, Taitian Lentiines,
freckles, eyebrow tattoo, body tattoo, lips tattoo.
2. Vascular lesion: Pigment with red, brown, blue and black;
vascular expanding
How it works? --- ExQ-Laser
Principle of Treatment
Treatment principle for pigmented dermatosis of Q-Switched Nd:YAG
Laser. Therapy system lies in selective photothermolysis with
melanin as the chromophore.
Q-Switched Nd:YAG has higher Peak power and nanoseconds-level pulse
width. Melanin in melanophore and cuticle formed cells have a short
hot relaxation time. It could immediately make small selectively
energy absorbed granules (tattoo pigment and melanin) blast without
injuring surrounded normal tissues. The blasted pigment granules
will be excreted from body through circulatory system.
Laser type: | High energy Q-Switched Nd:YAG |
Certification: | CFDA, TGA, TUV medical CE |
Wavelength: | 1064nm; 532nm |
Pulse width: | 8ns; 8ns |
Pulse energy: | 1000mJ; 500mJ |
Pulse energy Range: | 100~1000mJ; 100~500mJ |
Frequency: | 5Hz |
Spot size: | 2~10mm adjustable |
Diode Laser Feauture
ExQ-Laser™ is newly released Q-Switched Nd:YAG laser therapy system. The system has an optimal clinical treatment effect with following parameter designs: dual-wavelength switching of 1064nm & 532nm, pulse width short to 5ns and Energy output up to 1000mJ.
ExQ-Laser™ integrated with real-time energy monitor, energy auto-changing by adjustable handpiece, water filtration system, sufficiently guarantee the safety and efficiency during using. New UI designs focuse on user experience, make the operation simpler and more convenient.
ExQ-Laser™ is safety and reliable with excellent performance, has successively achieved Certificates from CFDA , Medical CE and Australian TGA .Its unique designs also earn multiple global patents
Quality Control
From every part to DHL delivery to you, step by step, we have
quality control.
Quality comes from our colleagues hard working and high quality
asking.
During 17 years, Sincoheren quality is good reputation over the
world.
Introduction
ExQ-Laser™ is newly released Q-Switched Nd:YAG laser therapy system. The system has an optimal clinical treatment effect with following parameter designs: dual-wavelength switching of 1064nm & 532nm, pulse width short to 5ns and Energy output up to 1000mJ.
ExQ-Laser™ integrated with real-time energy monitor, energy auto-changing by adjustable handpiece, water filtration system, sufficiently guarantee the safety and efficiency during using. New UI designs focuse on user experience, make the operation simpler and more convenient.
ExQ-Laser™ is safety and reliable with excellent performance, has successively achieved Certificates from CFDA , Medical CE and Australian TGA .Its unique designs also earn multiple global patents.
Contraindications
In clinical treatment, patients with following conditions are not allowed to take the treatment unless the impacting factors are eliminated.
1. Patients with endocrine disorder, cicatricial physics, damaged or infected skin and pigmentation idiosyncrasy.
2. Patients partially being applied with corticosteroid hormone in 2 weeks or having retinoid drugs in half a year.
3. Patients with active tuberculosis, hyperthyroidism and failure of heart, liver and kidney.
4. Light sensitive skin disease and photosensitivity drugs users.
5. Patients in pregnancy or suckling period.
6. Patients having dermatoma, cataract and aphakia or being treated with radiotherapy or isotope therapy.
7. Patient with history of melanoma, serious light injury and having taken ionizing radiation or arsenicals.
8. Patient with weakened immune system.
9. Patient with blood coagulation disorder.
10. Patient of mentally disorder, psychoneurosis and epileptics.
![]() |